Skip to main content
NCBI home page
Focus: Journal of Life Long Learning in Psychiatry logoLink to Focus: Journal of Life Long Learning in Psychiatry
. 2020 Apr 23;18(2):205–207. doi: 10.1176/appi.focus.18202

Challenges of Mood Disorders Care

PMCID: PMC7587890  PMID: 33162860

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and by topic. Articles from the bibliography that are reprinted in this issue are in bold type.

References

  1. D’Anci KE, Uhl S, Giradi G, et al. : Treatments for the prevention and management of suicide: a systematic review. Ann Intern Med 2019; 171:334–342 [DOI] [PubMed] [Google Scholar]
  2. Davies P, Ijaz S, Williams CJ, et al. : Pharmacological interventions for treatment-resistant depression in adults. Cochrane Database Syst Rev 2019; 12:CD010557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dunlop BW, LoParo D, Kinkead B, et al. : Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression. Am J Psychiatry 2019; 176:275–286 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. doi: 10.1016/S2215-0366(19)30217-2. Furukawa TA, Cipriani A, Cowen PJ, et al: Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry 2019; 6:601–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Greden JF, Parikh SV, Rothschild AJ, et al. : Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: a large, patient- and rater-blinded, randomized, controlled study. J Psychiatr Res 2019; 111:59–67 [DOI] [PubMed] [Google Scholar]
  6. Gunderson JG, Choi-Kain LW: Working with patients who self-injure. JAMA Psychiatry 2019; 76:976–977 [DOI] [PubMed] [Google Scholar]
  7. International Society of Psychiatric Genetics: Genetic testing and psychiatric disorders. https://ispg.net/genetic-testing-statement. First published March 2013, last updated March 2019
  8. doi: 10.1038/s41398-019-0460-3. Kraus C, Kadriu B, Lanzenberger R, et al: Prognosis and improved outcomes in major depression: a review. Transl Psychiatry 2019; 9:127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mutz J, Vipulananthan V, Carter B, et al. : Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ 2019; 364:11079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ochs-Ross R, Daly EJ, Zhang Y, et al. : Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression–TRANSFORM-3. Am J Geriatr Psychiatry 2020; 28:121–141 [DOI] [PubMed] [Google Scholar]
  11. Oquendo MA, Bernstein CA, Mayer LES: A key differential diagnosis for physicians-major depression or burnout? JAMA Psychiatry 2019 [DOI] [PubMed] [Google Scholar]
  12. doi: 10.1176/appi.ajp.2018.18070834. Phillips JL, Norris S, Talbot J, et al: Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry 2019; 176:401–409. [DOI] [PubMed] [Google Scholar]
  13. Popova V, Daly EJ, Trivedi M, et al. : Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry 2019; 176:428–438 [DOI] [PubMed] [Google Scholar]
  14. Rush AJ, Aaronson ST, Demyttenaere K: Difficult-to-treat depression: a clinical and research roadmap for when remission is elusive. Aust N Z J Psychiatry 2019; 53:109–118 [DOI] [PubMed] [Google Scholar]
  15. Zisook S, Johnson GR, Tal I, et al. : General predictors and moderators of depression remission: a VAST-D Report. Am J Psychiatry 2019; 176:348–357 [DOI] [PubMed] [Google Scholar]
  16. Caldeira C, Chen Y, Chan L, et al. : Mobile apps for mood tracking: an analysis of features and user reviews. AMIA Annu Symp Proc 2018; 2017:495–504 [PMC free article] [PubMed] [Google Scholar]
  17. Carlbring P, Andersson G, Cuijpers P, et al. : Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. Cogn Behav Ther 2018; 47:1–18 [DOI] [PubMed] [Google Scholar]
  18. Cipriani A, Furukawa TA, Salanti G, et al. : Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391:1357–1366 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Murri MB, Ekkekakis P, Menchetti M, et al. : Physical exercise for late-life depression: effects on symptom dimensions and time course. J Affect Disord 2018; 230:65–70 [DOI] [PubMed] [Google Scholar]
  20. doi: 10.1176/appi.ajp.2018.18040398. Rush AJ, Thase ME: Improving depression outcome by patient-centered medical management. Am J Psychiatry 2018; 175:1187–1198. [DOI] [PubMed] [Google Scholar]
  21. Stern S, Linker S, Vadodaria KC, et al. : Prediction of response to drug therapy in psychiatric disorders. Open Biol 2018; 8:180031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sullivan PF, Agrawal A, Bulik CM, et al. : Psychiatric genomics: an update and an agenda. Am J Psychiatry 2018; 175:15–27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thase ME, Wright JH, Eells TD, et al. : Improving the efficiency of psychotherapy for depression: computer-assisted versus standard CBT. Am J Psychiatry 2018; 175:242–250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wilkinson ST, Ballard ED, Bloch MH, et al. : The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry 2018; 175:150–158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Williams NR, Heifets BD, Blasey C, et al. : Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry 2018; 175:1205–1215 10.1176/appi.ajp.2018.18020138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zeier Z, Carpenter LL, Kalin NH, et al. : Clinical implementation of pharmacogenetic decision support tools for antidepressant drug prescribing. Am J Psychiatry 2018; 175:873–886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dunlop BW, Rajendra JK, Craighead WE, et al. : Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder. Am J Psychiatry 2017; 174:533–545 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Williams LM: Defining biotypes for depression and anxiety based on large-scale circuit dysfunction: a theoretical review of the evidence and future directions for clinical translation. Depress Anxiety 2017; 34:9–24 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sim K, Lau WK, Sim J, et al. : Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. Int J Neuropsychopharmacol 2015; 19:pyv076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mojtabai R, Olfson M: National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry 2010; 67:26–36 [DOI] [PubMed] [Google Scholar]

CBT for Depression

  1. Marshall JM, Dunstan DA, Bartik W: Clinical or gimmickal: the use and effectiveness of mobile mental health apps for treating anxiety and depression. Aust N Z J Psychiatry 2020; 54:20–28 [DOI] [PubMed] [Google Scholar]
  2. Torous J, Andersson G, Bertagnoli A, et al. : Towards a consensus around standards for smartphone apps and digital mental health. World Psychiatry 2019; 18:97–98 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Wright JH, Mishkind M, Eells TD, et al. : Computer-assisted cognitive-behavior therapy and mobile apps for depression and anxiety. Curr Psychiatry Rep 2019; 21:62. [DOI] [PubMed] [Google Scholar]
  4. Wright JH, Owen JJ, Richards D, et al. : Computer-assisted cognitive-behavior therapy for depression: a systematic review and meta-analysis. J Clin Psychiatry 2019; 80:18r12188. [DOI] [PubMed] [Google Scholar]
  5. Berman AL: Risk factors proximate to suicide and suicide risk assessment in the context of denied suicide ideation. Suicide Life Threat Behav 2018; 48:340–352 [DOI] [PubMed] [Google Scholar]
  6. Mehrotra S, Tripathi R: Recent developments in the use of smartphone interventions for mental health. Curr Opin Psychiatry 2018; 31:379–388 [DOI] [PubMed] [Google Scholar]
  7. Firth J, Torous J, Nicholas J, et al. : The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry 2017; 16:287–298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sudol K, Mann JJ: Biomarkers of suicide attempt behavior: towards a biological model of risk. Curr Psychiatry Rep 2017; 19:31. [DOI] [PubMed] [Google Scholar]
  9. Zalsman G, Hawton K, Wasserman D, et al. : Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry 2016; 3:646–659 [DOI] [PubMed] [Google Scholar]
  10. Eells TD, Barrett MS, Wright JH, et al. : Computer-assisted cognitive-behavior therapy for depression. Psychotherapy 2014; 51:191–197 [DOI] [PubMed] [Google Scholar]
  11. Dobson KS: A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol 1989; 57:414–419 [DOI] [PubMed] [Google Scholar]

Perinatal Depression

  1. Putnam KT, Wilcox M, Robertson-Blackmore E, et al. : Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium. Lancet Psychiatry 2017; 4:477–485 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Osborne L, Clive M, Kimmel M, et al. : Replication of epigenetic postpartum depression biomarkers and variation with hormone levels. Neuropsychopharmacology 2016; 41:1648–1658 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hoertel N, López S, Peyre H, et al. : Are symptom features of depression during pregnancy, the postpartum period and outside the peripartum period distinct? Results from a nationally representative sample using item response theory (IRT). Depress Anxiety 2015; 32:129–140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Maguire J, Mody I: GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron 2008; 59:207–213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bloch M, Schmidt PJ, Danaceau M, et al. : Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000; 157:924–930 [DOI] [PubMed] [Google Scholar]

Opioids and Depression

  1. Rockett IRH, Caine ED: Reconciling suicides with “accidental” drug-intoxication deaths: a behaviorally based definition of self-injury mortality. Am J Public Health 2020; 110:73–74 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bohnert ASB, Ilgen MA: Understanding links among opioid use, overdose, and suicide. N Engl J Med 2019; 380:71–79 [DOI] [PubMed] [Google Scholar]
  3. Stone DM, Holland KM, Bartholow B, et al. : Deciphering suicide and other manners of death associated with drug intoxication: a Centers for Disease Control and Prevention consultation meeting summary. Am J Public Health 2017; 107:1233–1239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bohnert ASB, Logan JE, Ganoczy D, et al. : A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain. Med Care 2016; 54:435–441 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Volkow ND, Frieden TR, Hyde PS, et al. : Medication-assisted therapies—tackling the opioid-overdose epidemic. N Engl J Med 2014; 370:2063–2066 [DOI] [PubMed] [Google Scholar]
  6. Wilcox HC, Conner KR, Caine ED: Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend 2004; 76(Suppl):S11–S19 [DOI] [PubMed] [Google Scholar]

Real-Time Monitoring and Precision Medicine

  1. Collins FS, Varmus H: A new initiative on precision medicine. N Engl J Med 2015; 372:793–795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Jain SH, Powers BW, Hawkins JB, et al. : The digital phenotype. Nat Biotechnol 2015; 33:462–463 [DOI] [PubMed] [Google Scholar]
  3. Lillie EO, Patay B, Diamant J, et al. : The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Per Med 2011; 8:161–173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Shiffman S, Stone AA, Hufford MR: Ecological momentary assessment. Annu Rev Clin Psychol 2008; 4:1–32 [DOI] [PubMed] [Google Scholar]
  5. Singh I, Rose N: Biomarkers in psychiatry. Nature 2009; 460:202–207 [DOI] [PubMed] [Google Scholar]

Children and Adolescents

  1. Iyengar U, Snowden N, Asarnow JR, et al. : A further look at therapeutic interventions for suicide attempts and self-harm in adolescents: an updated systematic review of randomized controlled trials. Front Psychiatry 2018; 9:583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burcu M, Zito JM, Safer DJ, et al. : Concomitant use of atypical antipsychotics with other psychotropic medication classes and the risk of type 2 diabetes mellitus. J Am Acad Child Adolesc Psychiatry 2017; 56:642–651 [DOI] [PubMed] [Google Scholar]
  3. Correll CU, Manu P, Olshanskiy V, et al. : Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009; 302:1765–1773 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Focus: Journal of Life Long Learning in Psychiatry are provided here courtesy of American Psychiatric Publishing

RESOURCES